Alaunos Therapeutics Inc (STU:WEK)
€ 1.66 0 (-4.82%) Market Cap: 338.23 Mil Enterprise Value: 276.94 Mil PE Ratio: 0 PB Ratio: 1.04 GF Score: 54/100

Q4 2021 Alaunos Therapeutics Inc Earnings Call Transcript

Mar 30, 2022 / 12:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Alaunos Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call. (Operator Instructions)

I would now like to turn the call over to your host, Alex Lobo, Stern Investor Relations. You may begin.

Alex Lobo

Good morning, and welcome to Alaunos Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call and Audio Webcast. With me today are Kevin Boyle Senior, Alaunos Therapeutics' Chief Executive Officer; Drew Deniger, Vice President of Research and Development; and Mike Wong, our Vice President of Finance.

Earlier this morning, Alaunos issued a press release announcing financial results for the 3 months and full year ended December 31, 2021. We encourage everyone to read today's press release as well as the Alaunos Annual Report on Form 10-K for the year ended December 31, 2021, which was filed this morning with the SEC.

The company's press release and annual report will also be available on the Alaunos website at alaunos.com. In

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot